Chris Thompson | Head of Reseach | Ubika Research | Chris@UbikaResearch.com | 1 (416) 574-0469
Patrick Smith | Analyst | Ubika Research | Patrick@UbikaResearch.com | 1 (647) 444-5506
Richard Waxman | Associate | Ubika Research | Richard@UbikaResearch.com | 1 (647) 770-2185
The Ubika Marijuana Stock Index soared 143% year-over-year, outperforming the Canadian cannabis sector as a whole
Ubika Marijuana 20 Index (March 19 - May 17)
UMJ20: -15.1% (142.9% Y/Y)
TSX-V: -5.6% (-3.3% Y/Y)
HMMJ: -10.4% (81.3% Y/Y)
Dollar amounts in CAD unless otherwise stated.
Top Volume Gainers (m/m)
Cannabis Sector Spotlight
The Ubika Marijuana Index continues to outperform on a year-over-year basis, sprouting 143% higher since this time last year. Comparatively, the Horizons
Marijuana Life Sciences Index (HMMJ) climbed 81% while the TSXV declined 3% YoY.
This report examines a growing Canadian marijuana company that has caught our attention with its vertically-integrated business model. Sunniva Inc. (CSE:SNN, OTCQX:SNNVF), a cannabis developer of medical marijuana with operations in British Colombia and California, has underperformed its benchmark, the HMMJ, (11% decline vs 8% decline) since it began trading in January 2018. The full report can be found below.
This Content is Exclusive to Our Members
To read our full disclosure, please click on the button below: